Navigation Links
Sponsor-A-Scientist: New Option to Fund Biomedical Research
Date:9/5/2009

PHILADELPHIA, Sept. 4 /PRNewswire-USNewswire/ -- The Sbarro Health Research Organization (www.shro.org), a nonprofit center for cancer, cardiovascular and diabetes research located at Temple University in Philadelphia and the University of Siena, Italy, has launched Sponsor-A-Scientist (http://cgi.ebay.com/ws/eBayISAPI.dll?ViewItem&item=270448425234&ssPageName=ADME:L:LCA:US:1123), an innovative program that allows interested individuals to bid on e-Bay for a named fellowship to support a talented young scientist for one academic year.

The fellowship, which can be named in honor of a relative or loved one, will support a year of study under the direction of Antonio Giordano, M.D., Ph.D., the Founder and President of SHRO, the Director of the Sbarro Institute for Cancer Research and Molecular Medicine, and the Director of the Center for Biotechnology in the College of Science & Technology at Temple University in Philadelphia, PA. Dr. Giordano is also a 'Chiara fama' professor at the University of Siena, in Siena, Italy.

Despite recent increases in the budgets of the National Institutes of Health, which funds much of the country's biomedical research, dollars to pay for expensive research remain hard to come by for graduate and post-graduate students. Sponsor-A-Scientist's goal is to bring attention to and support for the work of young and gifted researchers, while giving the public an opportunity to be more directly involved in new and exciting medical discoveries.

"SHRO is at the forefront of molecular genetic discoveries in cancer and cardiovascular disease and in innovative methods to fund our important research," says Giordano. "This new initiative is an extension of our drive to support talented researchers and to uncover new resources to continue our work."

Bids for the Sponsor-A-Scientist program start at $25,000.

About the Sbarro Health Research Organization

Sbarro Health Research Organization is committed to excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. The Sbarro Health Research Organization funds the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA.

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.


'/>"/>
SOURCE Sbarro Health Research Organization
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pelosi: Public Option Best Way to Control Costs, Promote Competition
2. United Concordia Dental Expands Benefit Options
3. New Options Available for the 13 Million Men Who Suffer from Testosterone Deficiency
4. Watchful waiting is a viable option for prostate cancer patients with low-risk tumors
5. Secca(R) Therapy - An Effective and Minimally Invasive Option for Treating Bowel Incontinence - Launched in the US
6. Home Dialysis a Good Option for Kidney Disease Patients
7. U.S. Senate Candidate Cheryle Jackson: Public Option Critical to Real Health Care Reform
8. Healthcare: Public Option Mirrors Other Government Insurance Plans
9. Georgia Reproductive Specialists Free Infertility Seminar: Fertility Options 101
10. Fattah Advocates D.C. March for Healthcare By the Supporters of Reform with Public Option
11. Stenting a Good Option for Left Main Heart Artery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: